Graftys

Graftys is a biotechnology startup founded in 2005. Based in Belgium and France, the company focuses on developing, manufacturing, and marketing patented synthetic bone biomaterials, particularly new generations of resorbable calcium-phosphate cements for reconstructive orthopedic surgery. With a presence in over 25 countries, including Europe and the United States of America, Graftys has established distribution partnerships to commercialize its products. The company's objective is to expand its product lines by introducing new versions of existing products and developing new products with enhanced regenerative properties.

In its most recent funding round, Graftys secured a €2.00M Venture Round investment on 19 July 2022. The investors in this round included Quest Venture Partners, Go Capital, Noshaq, and the Innovation Fund. The investment signifies trust and support from prominent venture capital firms, indicating potential promise and growth prospects for Graftys in the biotechnology, health care, health and wellness, and sports industries.